Greenwich LifeSciences
(NASDAQ) GLSI
Greenwich LifeSciences Financials at a Glance
Market Cap
$353.16M
Revenue (TTM)
$0.00
Net Income (TTM)
-$21.76M
EPS (TTM)
-$1.55
P/E Ratio
-15.54
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$24.08
Volume
3,569
Open
$23.51
Price
$24.08
Volume
3,569
Open
$23.51
Previous Close
$24.08
Daily Range
$23.51 - $24.19
52-Week Range
$7.78 - $34.10
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$24.08
Volume
3,569
Open
$23.51
Previous Close
$24.08
Daily Range
$23.51 - $24.19
52-Week Range
$7.78 - $34.10
Estimated Earnings Date
Aug 13, 2026
GLSI News
GLSI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Greenwich LifeSciences
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Snehal S. Patel, MBA
Headquarters
Stafford, TX 77477, US
GLSI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-661%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
-6.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$353.16M
Shares Outstanding
14.68M
Volume
3.57K
Avg. Volume
152.11K
Financials (TTM)
Gross Profit
-$1.78K
Operating Income
-$19.45M
EBITDA
-$19.36M
Operating Cash Flow
-$9.91M
Capital Expenditure
$3.00
Free Cash Flow
-$9.91M
Cash & ST Invst.
-$6.74M
Total Debt
$0.00
Greenwich LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$353.16M
N/A
Market Cap/Employee
$88.29M
N/A
Employees
4
N/A
Net Income
-$5.66M
-106.1%
EBITDA
-$5.66M
-106.2%
Quarterly Fundamentals
Total Cash
$10.51M
+282.0%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.07%
N/A
Return on Invested Capital
-4.15%
N/A
Free Cash Flow
-$4.70M
-156.3%
Operating Cash Flow
-$4.70M
-156.3%